Overview

To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm equivalent bronchodilator efficacy of the test product compared to the reference product.
Phase:
Phase 3
Details
Lead Sponsor:
Orion Corporation, Orion Pharma
Treatments:
Bronchodilator Agents
Budesonide
Budesonide, Formoterol Fumarate Drug Combination
Formoterol Fumarate